Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**SKAP1 antisense RNA 1 (SKAP1-AS1)**, also known as **RP11-456D7.1**, is a long non-coding RNA transcribed from the antisense strand of the SKAP1 locus[3][4]. As a natural antisense transcript (NAT), it is classified as a non-coding RNA and is not translated into protein[6]. The general role of antisense RNAs, including lncRNAs like SKAP1-AS1, is to regulate gene expression through mechanisms such as transcriptional interference, modulation of chromatin structure, or RNA-RNA interactions. These actions may impact the expression of the sense gene (SKAP1) or other regulatory processes[2][6]. There is no published evidence that SKAP1-AS1 functions as a therapeutic target, nor is there information on clinical drugs or biomarker use specific to this RNA. The broader class of antisense RNAs is under investigation for roles in disease, but no direct association with specific diseases or therapeutic interventions is currently documented for SKAP1-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SKAP1 antisense RNA 1 (SKAP1-AS1).